Evidence map›Paper›PMID 31575891›Full record

ArticleScientific reports2019

Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein.

Miroslav P Milev, Daniela Stanga, Anne Schänzer, Andrés Nascimento, Djenann Saint-Dic, Carlos Ortez, Daniel Natera-de Benito, Desiré González Barrios, Jaume Colomer, Carmen Badosa and 9 more

Erratum issuedOpen access · goldAbstract readCase Reports
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Expanding the phenotypic spectrum ofJournal of medical genetics · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 4 countries.

Miroslav P MilevConcordia University, Department of Biology, Montreal, Quebec, Canada.
Daniela StangaConcordia University, Department of Biology, Montreal, Quebec, Canada.
Anne SchänzerInstitute of Neuropathology, Justus Liebig University Giessen, Giessen, Germany.
Andrés NascimentoNeuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Djenann Saint-DicConcordia University, Department of Biology, Montreal, Quebec, Canada.
Carlos OrtezNeuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Daniel Natera-de BenitoNeuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Desiré González BarriosServicio de Pediatría, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Jaume ColomerNeuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Carmen BadosaNeuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Cristina JouU705 and U703 Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Pia GallanoU705 and U703 Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Lidia Gonzalez-QueredaU705 and U703 Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Ana TöpfThe John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.
Katherine JohnsonThe John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.
Volker StraubThe John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.
Andreas HahnDepartment of Child Neurology, Justus Liebig University Giessen, Giessen, Germany. Andreas.Hahn@paediat.med.uni-giessen.de.
Michael SacherConcordia University, Department of Biology, Montreal, Quebec, Canada. michael.sacher@concordia.ca.
Cecilia Jimenez-MallebreraNeuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain. cjimenezm@fsjd.org.
Hospital Sant Joan de Déu Barcelona · ESConcordia University · CACentre for Biomedical Network Research on Rare Diseases · ESInstitut de Recerca Sant Joan de DéuJustus-Liebig-Universität Gießen · DENewcastle University · GBHospital de Sant Pau · ESHospital Universitario Nuestra Señora de Candelaria · ESMcGill University · CANewcastle upon Tyne Hospitals NHS Foundation Trust · GB

Funding

Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
CIHRNHGRI NIH HHS UM1 HG008900
6 · The paper itself

Abstract

TRAPPC11 was identified as a component of the TRAPP III complex that functions in membrane trafficking and autophagy. Variants in TRAPPC11 have been reported to be associated with a broad spectrum of phenotypes but all affected individuals display muscular pathology. Identifying additional variants will further our understanding of the clinical spectrum of phenotypes and will reveal regions of the protein critical for its functions. Here we report three individuals from unrelated families that have bi-allellic TRAPPC11 variants. Subject 1 harbors a compound heterozygous variant (c.1287 + 5G > A and c.3379_3380insT). The former variant results in a partial deletion of the foie gras domain (p.Ala372_Ser429del), while the latter variant results in a frame-shift and extension at the carboxy terminus (p.Asp1127Valfs*47). Subjects 2 and 3 both harbour a homozygous missense variant (c.2938G > A; p.Gly980Arg). Fibroblasts from all three subjects displayed membrane trafficking defects manifested as delayed endoplasmic reticulum (ER)-to-Golgi transport and/or a delay in protein exit from the Golgi. All three individuals also show a defect in glycosylation of an ER-resident glycoprotein. However, only the compound heterozygous subject displayed an autophagic flux defect. Collectively, our characterization of these individuals with bi-allelic TRAPPC11 variants highlights the functional importance of the carboxy-terminal portion of the protein.

Indexed as

BrainChild, PreschoolFemaleGene FrequencyGenetic Diseases, InbornGenetic VariationHumansInfantMagnetic Resonance ImagingMaleMuscle HypotoniaMuscle, SkeletalVesicular Transport ProteinsTRAPPC11 protein, humanVesicular Transport Proteins

Identifiers

PMID31575891
PMCPMC6773699
OpenAlexW2977381403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.